183 related articles for article (PubMed ID: 7897213)
1. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
Jackson JR; Sathe G; Rosenberg M; Sweet R
J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213
[TBL] [Abstract][Full Text] [Related]
2. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
[TBL] [Abstract][Full Text] [Related]
4. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
5. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
6. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
7. In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants.
De Pascalis R; Gonzales NR; Padlan EA; Schuck P; Batra SK; Schlom J; Kashmiri SV
Clin Cancer Res; 2003 Nov; 9(15):5521-31. PubMed ID: 14654532
[TBL] [Abstract][Full Text] [Related]
8. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.
Ames RS; Tornetta MA; McMillan LJ; Kaiser KF; Holmes SD; Appelbaum E; Cusimano DM; Theisen TW; Gross MS; Jones CS
J Immunol; 1995 Jun; 154(12):6355-64. PubMed ID: 7759873
[TBL] [Abstract][Full Text] [Related]
10. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
[TBL] [Abstract][Full Text] [Related]
11. Affinity maturation of a V(H)H by mutational hotspot randomization.
Yau KY; Dubuc G; Li S; Hirama T; Mackenzie CR; Jermutus L; Hall JC; Tanha J
J Immunol Methods; 2005 Feb; 297(1-2):213-24. PubMed ID: 15777944
[TBL] [Abstract][Full Text] [Related]
12. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
Parhami-Seren B; Margolies MN
J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
[TBL] [Abstract][Full Text] [Related]
13. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
[TBL] [Abstract][Full Text] [Related]
14. Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope.
Lowe DC; Gerhardt S; Ward A; Hargreaves D; Anderson M; Ferraro F; Pauptit RA; Pattison DV; Buchanan C; Popovic B; Finch DK; Wilkinson T; Sleeman M; Vaughan TJ; Mallinder PR
J Mol Biol; 2011 Feb; 406(1):160-75. PubMed ID: 21167836
[TBL] [Abstract][Full Text] [Related]
15. Generation of anti-p53 Fab fragments from individuals with colorectal cancer using phage display.
Coomber DW; Hawkins NJ; Clark MA; Ward RL
J Immunol; 1999 Aug; 163(4):2276-83. PubMed ID: 10438972
[TBL] [Abstract][Full Text] [Related]
16. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
17. Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection.
Figini M; Obici L; Mezzanzanica D; Griffiths A; Colnaghi MI; Winter G; Canevari S
Cancer Res; 1998 Mar; 58(5):991-6. PubMed ID: 9500461
[TBL] [Abstract][Full Text] [Related]
18. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
19. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
20. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
